Efficacy News and Research

RSS
Rerouting dead tumor debris enhances cancer immunotherapy outcomes

Rerouting dead tumor debris enhances cancer immunotherapy outcomes

Ensitrelvir cuts household COVID-19 risk when given after exposure

Ensitrelvir cuts household COVID-19 risk when given after exposure

Biomimetic nanocomposite hydrogel promotes tendon healing and tissue regeneration

Biomimetic nanocomposite hydrogel promotes tendon healing and tissue regeneration

Methylene blue enhances hair follicle stem cell regeneration under stress

Methylene blue enhances hair follicle stem cell regeneration under stress

Study supports flexible blood transfusion options in emergency trauma care

Study supports flexible blood transfusion options in emergency trauma care

How antibody-drug conjugates are redefining targeted cancer therapy

How antibody-drug conjugates are redefining targeted cancer therapy

New therapies could help type 1 diabetes care move beyond insulin alone

New therapies could help type 1 diabetes care move beyond insulin alone

Tezepelumab reduces asthma exacerbations in diverse patient population

Tezepelumab reduces asthma exacerbations in diverse patient population

New guidelines for identifying and treating high-risk IEC-HS patients

New guidelines for identifying and treating high-risk IEC-HS patients

How Andes virus super-spreaders reveal the risk behind the MV Hondius hantavirus cluster

How Andes virus super-spreaders reveal the risk behind the MV Hondius hantavirus cluster

Thyroid hormone profiles provide critical prognostic clues for patients facing liver failure

Thyroid hormone profiles provide critical prognostic clues for patients facing liver failure

Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C

Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C

Sequential TACE after SBRT improves outcomes in recurrent hepatocellular carcinoma

Sequential TACE after SBRT improves outcomes in recurrent hepatocellular carcinoma

Qureight to support Mediar Therapeutics' Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis

Qureight to support Mediar Therapeutics' Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis

Base editing approach repairs deadly Dravet syndrome mutation in mice

Base editing approach repairs deadly Dravet syndrome mutation in mice

Experts urge WHO to strengthen airborne virus precautionary measures

Experts urge WHO to strengthen airborne virus precautionary measures

Obesity drugs and surgery linked to greater fat-free mass loss

Obesity drugs and surgery linked to greater fat-free mass loss

New drug carrier improves cancer treatment by anchoring to tumors

New drug carrier improves cancer treatment by anchoring to tumors

Once-daily orforglipron helps preserve weight loss after semaglutide or tirzepatide

Once-daily orforglipron helps preserve weight loss after semaglutide or tirzepatide

Rhein protects against intestinal injury in severe acute pancreatitis

Rhein protects against intestinal injury in severe acute pancreatitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.